These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23323859)

  • 21. The combination of photodynamic therapy and fractional CO
    Yao Y; Shen X; Shi L; Tang G; Wu L
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101597. PubMed ID: 31707101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laser surgery as a treatment for oral leukoplakia.
    Ishii J; Fujita K; Komori T
    Oral Oncol; 2003 Dec; 39(8):759-69. PubMed ID: 13679199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laser management of oral leukoplakias: a follow-up study of 70 patients.
    Schoelch ML; Sekandari N; Regezi JA; Silverman S
    Laryngoscope; 1999 Jun; 109(6):949-53. PubMed ID: 10369289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lesion characteristics and responses after CO2 laser vaporization in five patients With gingival leukoplakia.
    Chainani-Wu N; Silverman S
    J Calif Dent Assoc; 2013 Oct; 41(10):759-62, 765. PubMed ID: 24340428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical management of premalignant lesions of the oral cavity with the CO2 laser.
    Pinheiro AL; Frame JW
    Braz Dent J; 1996; 7(2):103-8. PubMed ID: 9206362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon dioxide laser evaporation of leukoplakia of the lower lip: a retrospective evaluation.
    Gooris PJ; Roodenburg JL; Vermey A; Nauta JM
    Oral Oncol; 1999 Sep; 35(5):490-5. PubMed ID: 10694949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.
    Yang SW; Lee YS; Chang LC; Yang CH; Luo CM; Wu PW
    Clin Oral Investig; 2021 Jun; 25(6):4045-4058. PubMed ID: 33411001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of CO2 laser vaporization for oral potentially malignant disorders treatment.
    Cloitre A; Rosa RW; Arrive E; Fricain JC
    Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e237-e247. PubMed ID: 29476671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clincopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients.
    Yang SW; Lee YS; Chang LC; Hwang CC; Chen TA
    Head Neck; 2020 May; 42(5):1014-1023. PubMed ID: 31930772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbon dioxide laser fiber for the excision of oral leukoplakia.
    Chee M; Sasaki C
    Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):547-9. PubMed ID: 24224396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A feasible procedure in dental practice: the treatment of oral dysplastic hyperkeratotic lesions of the oral cavity with the CO2 laser.
    Santos NR; Aciole GT; Marchionni AM; Soares LG; dos Santos JN; Pinheiro AL
    Photomed Laser Surg; 2010 Oct; 28 Suppl 2():S121-6. PubMed ID: 20929389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.
    Thomson PJ; Wylie J
    Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An anatomical perspective on clinicopathological characteristics and treatment outcomes of dorsal and ventrolateral tongue leukoplakia after carbon dioxide laser surgery.
    Yang SW; Lee YS; Chang LC; Yang CH; Luo CM
    BMC Oral Health; 2021 Jan; 21(1):45. PubMed ID: 33509189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers: a comparison.
    Lim B; Smith A; Chandu A
    J Oral Maxillofac Surg; 2010 Mar; 68(3):597-601. PubMed ID: 20171477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative recurrence as an associated factor of malignant transformation of oral dysplastic leukoplakia.
    Yang SW; Wu CJ; Lee YS; Chen TA; Tsai CN
    ORL J Otorhinolaryngol Relat Spec; 2010; 72(5):280-90. PubMed ID: 20798565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with CO
    Galletta V; Azevedo L; Lodi G; Migliari D
    J Contemp Dent Pract; 2017 Sep; 18(9):775-780. PubMed ID: 28874640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of oral leukoplakia with an 808-nm high-power diode laser: a single-center experience.
    de Arruda JAA; Silva LVO; Kato CNAO; Pinheiro JJV; Abreu LG; Silva TA; Ferreira MVL; Souza LN; Mesquita RA
    Lasers Med Sci; 2023 Jun; 38(1):141. PubMed ID: 37335418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management of actinic cheilitis.
    Satorres Nieto M; Gargallo Albiol J; Gay Escoda C
    Med Oral; 2001; 6(3):205-17. PubMed ID: 11500638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of the carbon dioxide laser in the treatment of leukoplakia].
    Gáspár L; Szabó G
    Fogorv Sz; 1990 Mar; 83(3):65-9. PubMed ID: 2108879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dissertations 25 years after date 29. CO2 laser surgery of leukoplakia of the oral mucosa].
    Roodenburg JL
    Ned Tijdschr Tandheelkd; 2011 Oct; 118(10):496-500. PubMed ID: 22043641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.